Literature DB >> 33441939

Differences in the bacteriome of swab, saliva, and tissue biopsies in oral cancer.

Divya Gopinath1,2, Rohit Kunnath Menon3, Chong Chun Wie4, Moinak Banerjee5, Swagatika Panda6, Deviprasad Mandal6, Paresh Kumar Behera7, Susanta Roychoudhury8, Supriya Kheur9, Michael George Botelho10, Newell W Johnson11,12,13.   

Abstract

Microbial dysbiosis has been implicated in the pathogenesis of oral cancer. We analyzed the compositional and metabolic profile of the bacteriome in three specific niches in oral cancer patients along with controls using 16SrRNA sequencing (Illumina Miseq) and DADA2 software. We found major differences between patients and control subjects. Bacterial communities associated with the tumor surface and deep paired tumor tissue differed significantly. Tumor surfaces carried elevated abundances of taxa belonging to genera Porphyromonas, Enterobacteriae, Neisseria, Streptococcus and Fusobacteria, whereas Prevotella, Treponema, Sphingomonas, Meiothermus and Mycoplasma genera were significantly more abundant in deep tissue. The most abundant microbial metabolic pathways were those related to fatty-acid biosynthesis, carbon metabolism and amino-acid metabolism on the tumor surface: carbohydrate metabolism and organic polymer degradation were elevated in tumor tissues. The bacteriome of saliva from patients with oral cancer differed significantly from paired tumor tissue in terms of community structure, however remained similar at taxonomic and metabolic levels except for elevated abundances of Streptococcus, Lactobacillus and Bacteroides, and acetoin-biosynthesis, respectively. These shifts to a pro-inflammatory profile are consistent with other studies suggesting oncogenic properties. Importantly, selection of the principal source of microbial DNA is key to ensure reliable, reproducible and comparable results in microbiome studies.

Entities:  

Year:  2021        PMID: 33441939      PMCID: PMC7806708          DOI: 10.1038/s41598-020-80859-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  94 in total

Review 1.  Emerging and established global life-style risk factors for cancer of the upper aero-digestive tract.

Authors:  Bhawna Gupta; Newell W Johnson
Journal:  Asian Pac J Cancer Prev       Date:  2014

2.  Microbes involved in dissimilatory nitrate reduction in the human large intestine.

Authors: 
Journal:  FEMS Microbiol Ecol       Date:  2000-01-01       Impact factor: 4.194

3.  Concentration- and stage-specific effects of nitrite on colon cancer cell lines.

Authors:  Hong Jiang; Yaoping Tang; Harsha K Garg; Deepa K Parthasarathy; Ashley C Torregrossa; Norman G Hord; Nathan S Bryan
Journal:  Nitric Oxide       Date:  2012-04-05       Impact factor: 4.427

4.  Site-specific programming of the host epithelial transcriptome by the gut microbiota.

Authors:  Felix Sommer; Intawat Nookaew; Nina Sommer; Per Fogelstrand; Fredrik Bäckhed
Journal:  Genome Biol       Date:  2015-03-28       Impact factor: 13.583

5.  Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.

Authors:  Adi Binder Gallimidi; Stuart Fischman; Brurya Revach; Raanan Bulvik; Alina Maliutina; Ariel M Rubinstein; Gabriel Nussbaum; Michael Elkin
Journal:  Oncotarget       Date:  2015-09-08

6.  Acidic extracellular microenvironment and cancer.

Authors:  Yasumasa Kato; Shigeyuki Ozawa; Chihiro Miyamoto; Yojiro Maehata; Atsuko Suzuki; Toyonobu Maeda; Yuh Baba
Journal:  Cancer Cell Int       Date:  2013-09-03       Impact factor: 5.722

7.  Exposure to the gut microbiota drives distinct methylome and transcriptome changes in intestinal epithelial cells during postnatal development.

Authors:  Wei-Hung Pan; Felix Sommer; Maren Falk-Paulsen; Thomas Ulas; Philipp Best; Antonella Fazio; Priyadarshini Kachroo; Anne Luzius; Marlene Jentzsch; Ateequr Rehman; Fabian Müller; Thomas Lengauer; Jörn Walter; Sven Künzel; John F Baines; Stefan Schreiber; Andre Franke; Joachim L Schultze; Fredrik Bäckhed; Philip Rosenstiel
Journal:  Genome Med       Date:  2018-04-13       Impact factor: 11.117

8.  miPrimer: an empirical-based qPCR primer design method for small noncoding microRNA.

Authors:  Shih-Ting Kang; Wei-Ming Chen; Yi-Shan Hsieh; Chi-Ting Feng; Yu-Ting Chen; Pok Eric Yang
Journal:  RNA       Date:  2017-12-05       Impact factor: 4.942

Review 9.  Dysbiosis of gut microbiota in promoting the development of colorectal cancer.

Authors:  Shaomin Zou; Lekun Fang; Mong-Hong Lee
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-10-11
View more
  4 in total

1.  Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.

Authors:  Isabella Kuniko T M Takenaka; Thais F Bartelli; Alexandre Defelicibus; Juan M Sendoya; Mariano Golubicki; Juan Robbio; Marianna S Serpa; Gabriela P Branco; Luana B C Santos; Laura C L Claro; Gabriel Oliveira Dos Santos; Bruna E C Kupper; Israel T da Silva; Andrea S Llera; Celso A L de Mello; Rachel P Riechelmann; Emmanuel Dias-Neto; Soledad Iseas; Samuel Aguiar; Diana Noronha Nunes
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

2.  Mapping bacterial diversity and metabolic functionality of the human respiratory tract microbiome.

Authors:  Leonardo Mancabelli; Christian Milani; Federico Fontana; Gabriele Andrea Lugli; Chiara Tarracchini; Francesca Turroni; Douwe van Sinderen; Marco Ventura
Journal:  J Oral Microbiol       Date:  2022-03-16       Impact factor: 5.474

Review 3.  Microbiota and Oral Cancer as A Complex and Dynamic Microenvironment: A Narrative Review from Etiology to Prognosis.

Authors:  Pamela Pignatelli; Federica Maria Romei; Danilo Bondi; Michele Giuliani; Adriano Piattelli; Maria Cristina Curia
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

Review 4.  Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma.

Authors:  Zoya Kurago; Jenni Loveless
Journal:  Front Oral Health       Date:  2021-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.